Long-term Investing: Ecosystem with an edge called India; 12 large- mid- and small-cap stocks with upside potential of up to 34%Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...
23 May, 2026, 10.24 PM IST
These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 25%Here’s a thing investors in equity need to keep in mind. A large part of the upmove one might see in the next one or two trading sessions w...
18 May, 2026, 10.31 PM IST
These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 25%It is tough to think positively about the markets when all the news is about blockades, wars, and everything that can disturb the global ec...
13 Apr, 2026, 11.14 PM IST
GlaxoSmithKline consumer healthcare Q4 up 8.4% to Rs 176 croreTotal income from operations was Rs 1208.76 crore in Q4, up from Rs 1192.22 crore in the corresponding period last fiscal, a company statem...
11 May, 2017, 09.02 PM IST
Hit by strike, GSK Consumer suspends ops at Punjab plantThe company added that it took the step "in the interest of safety and security of its employees and to protect the assets of the factory".
23 May, 2016, 12.32 PM IST
- Buy GSK Consumer Healthcare Ltd with a target of Rs 5490: Sandeep Wagle
"GSK Consumer Healthcare Ltd is a 'BUY' call with a target of Rs 5490 and a stop loss of Rs 5085."
27 Aug, 2014, 09.11 AM IST
GlaxoSmithKline Consumer Healthcare Q1 profit up 8.46 per cent at Rs 130.12 croreNet sales of the company rose by 8.04% to Rs 921.55 cr in the April-June quarter as against Rs 852.92 crore in the corresponding period las...
06 Aug, 2014, 08.29 PM IST
GlaxoSmithKline Consumer Healthcare Ltd India-Novartis deal won't affect business in IndiaGlaxoSmithKline Consumer Healthcare today said the global deal between GlaxoSmithKline Plc and Novartis won't affect its business in India.
22 Apr, 2014, 05.44 PM IST
NSE to drop GlaxoSmithKline Consumer from F&O segmentNSE said it will exclude GlaxoSmithKline Consumer Healthcare from the Futures and Options segment with effect from May 30.
20 Mar, 2014, 08.43 PM IST
GlaxoSmithKline Consumer expands Horlicks portfolioHorlicks Kesar Badaam is the fourth variant in the Horlicks portfolio; the other flavours available are Malt, Chocolate and Elaichi.
17 Jan, 2014, 08.39 PM IST
- GlaxoSmithKline Plc's open offer for GSKCH to start on January 17
The UK-based GlaxoSmithKline Plc's open offer to acquire 31.8 per cent stake in its Indian subsidiary GlaxoSmithKline Consumer Healthcare w...
04 Dec, 2012, 09.32 PM IST
GSK to raise stake in GlaxoSmithKline Consumer Healthcare via open offerGlaxoSmithKline plans to raise its stake in its Indian consumer products arm to 75 per cent from 43.16 per cent through an open offer.
26 Nov, 2012, 11.38 AM IST
- GSK Consumer hits record high on parent company's plan to raise its stake
GSK Consumer surged 20% to hit its record high in early trade after its parent plans to raise its stake in Indian arm to 75%.
26 Nov, 2012, 10.11 AM IST
- GlaxoSmithkline Consumer Q3 net up 25 pc at Rs 128.55 cr
GlaxoSmithkline Consumer Healthcare Ltd today reported 24.76 per cent jump in net profit at Rs 128.55 crore for the third quarter ended Sep...
01 Nov, 2012, 06.19 PM IST
- GlaxoSmithkline Healthcare Q1 net up 19 per cent at Rs 132 crore
GlaxoSmithkline Consumer Healthcare (GSKCH) today said its net profit rose 19.30 per cent to Rs 131.97 crore for the first quarter ended Ma...
07 May, 2012, 05.47 PM IST
- GSK re-enters oral care market with Sensodyne
Sensodyne, GSK's biggest global brand with an annual sales of $750 million, has close to a 10% share of the US toothpaste market.
06 Jan, 2011, 05.49 AM IST
- GSK Consumer Healthcare net up 30 pc at Rs 71.75 cr
GlaxoSmithKline Consumer Healthcare Ltd reported a 30 per cent jump in net profit for the quarter ended June 30, 2010 at Rs 71.75 crore fro...
02 Aug, 2010, 07.56 PM IST